Health Care & Life Sciences » Pharmaceuticals » Orphan drugs | Therapeutic company pipeline for orphan designated drug programs US 2017

U.S. emerging therapeutic company pipeline for orphan designated drug programs 2017

Number of orphan designated products currently being developed by emerging therapeutic U.S. companies as of March 2017
Created with Highcharts 5.0.14108108393393177177121254546262Phase IPhase IIPhase III0100200300400500

The data displays the number of orphan designated drugs currently being developed by emerging therapeutic companies in the United States, as of March 2017. As of this time, of the 806 orphan programs being developed, over half were in Phase II of development.

Phase I 108 12
Phase II 393 54
Phase III 177 62

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.